CCIA
REGN icon

Campbell & Co Investment Adviser’s Regeneron Pharmaceuticals REGN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.17M Buy
+9,899
New +$6.74M 0.32% 43
2025
Q3 		– Sell
-1,345
Closed -$706K – 1343
2025
Q2 		$706K Buy
+1,345
New +$751K 0.04% 654
2025
Q1 		– Sell
-6,882
Closed -$4.9M – 1287
2024
Q4 		$4.9M Buy
6,882
+2,711
+65% +$2.28M 0.38% 46
2024
Q3 		$4.38M Buy
+4,171
New +$4.64M 0.33% 46
2023
Q1 		– Sell
-863
Closed -$623K – 998
2022
Q4 		$623K Sell
863
-2,118
-71% -$1.56M 0.15% 226
2022
Q3 		$2.05M Buy
+2,981
New +$1.88M 0.47% 23
2020
Q4 		– Sell
-800
Closed -$448K – 539
2020
Q3 		$448K Buy
800
+400
+100% +$243K 0.33% 92
2020
Q2 		$249K Buy
+400
New +$227K 0.32% 149
2019
Q3 		– Sell
-921
Closed -$288K – 737
2019
Q2 		$288K Sell
921
-1,468
-61% -$489K 0.13% 320
2019
Q1 		$981K Buy
2,389
+1,713
+253% +$705K 0.48% 26
2018
Q4 		$280K Buy
+676
New +$247K 0.28% 175
2018
Q1 		– Sell
-1,135
Closed -$427K – 508
2017
Q4 		$427K Sell
1,135
-1,081
-49% -$438K 0.32% 94
2017
Q3 		$991K Buy
+2,216
New +$1.05M 0.8% 14
2013
Q4 		– Sell
-2,802
Closed -$877K – 293
2013
Q3 		$877K Buy
+2,802
New +$737K 0.17% 145

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Campbell & Co Investment Adviser's REGN Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 9,899 shares worth $6.17M. The stake represents 0.32% of the portfolio and ranks #43 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in REGN as recently as Q2 2025.

Campbell & Co Investment Adviser first reported a position in REGN in Q3 2013 and has held it in 14 quarters since. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Campbell & Co Investment Adviser held 9,899 shares of Regeneron Pharmaceuticals worth $6.17M as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.32% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #43 holding.
  • Campbell & Co Investment Adviser first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.